Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

Inclusion Criteria: * Chronic central serous chorioretinopathy (CSCR) with persistent subretinal fluid on OCT for more than 3 months after initial presentation . * Written informed consent Exclusion Criteria: * Persons with impaired decision-making ability. * Pregnant women or who are actively trying to conceive. * Additional eye disease affecting the macula or posterior retina. * Creatinine clearance \< 50 ml/min * Hyperkalemia \> 5 mmol/l * Serum creatinine \> 2 mg/dl in men or \> 1.8 mg/dl in women * Treatment with potassium sparing agents or potassium * Treatment with any other drugs known to cause interaction with eplerenone * Microalbuminuria in patients with type 2 diabetes